Campos; Sebastien Andre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Campos; Sebastien Andre.The latest application filed is for "chemical compounds".

Company Profile

7.8.14

Campos; Sebastien Andre - Stevenage GB
Campos; Sebastien Andre - Hertfordshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chemical compounds Grant 10,793,559 - Anderson , et al. October 6, 2	2020-10-06
Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase Grant 10,730,862 - Crews , et al.	2020-08-04
Chemical Compounds App 20200071311 - ANDERSON; Niall Andrew ; et al.	2020-03-05
Chemical compounds Grant 10,457,674 - Anderson , et al. Oc	2019-10-29
Chemical Compounds App 20190161480 - CAMPOS; Sebastien Andre ; et al.	2019-05-30
Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase App 20190127359 - CREWS; CRAIG M. ; et al.	2019-05-02
Chemical Compounds App 20190040051 - ANDERSON; Niall Andrew ; et al.	2019-02-07
Compounds Grant 9,993,514 - Campos , et al. June 12, 2	2018-06-12
Benzothiophene derivatives as estrogen receptor inhibitors Grant 9,988,376 - Campos , et al. June 5, 2	2018-06-05
Benzothiophene Derivatives As Estrogen Receptor Inhibitors App 20160368911 - CAMPOS; Sebastien Andre ; et al.	2016-12-22
Novel Compounds App 20160136230 - CAMPOS; Sebastien Andre ; et al.	2016-05-19
Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase App 20140356322 - Crews; Craig M. ; et al.	2014-12-04
Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases Grant 8,575,181 - Campos , et al. November 5, 2	2013-11-05
Purine Derivatives For Use In The Treatment Of Allergic, Inflammatory And Infectious Diseases App 20110135670 - Campos; Sebastien Andre ; et al.	2011-06-09
Pyrrolopyridine Compounds, Process For Their Preparation, And Their Use As Medicaments App 20100179139 - Bamborough; Paul ; et al.	2010-07-15
Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis Grant 7,687,532 - Campos , et al. March 30, 2	2010-03-30
Pyrrolo[2,3-b]pyridin-4-yl-benzenesulfonamide Compounds As 1kk2 Inhibitors App 20100035917 - Bamborough; Paul ; et al.	2010-02-11
Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors App 20090023725 - Bamborough; Paul ; et al.	2009-01-22
Novel Compounds App 20080176891 - Bamborough; Paul ; et al.	2008-07-24
Novel Compounds App 20080146606 - Bamborough; Paul ; et al.	2008-06-19
Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis App 20070142372 - Campos; Sebastien Andre ; et al.	2007-06-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.